Acid Green 50 parent

Details

Stereochemistry	ACHIRAL
Molecular Formula	C27H26N2O7S2
Molecular Weight	554.635
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(C)C1=CC=C(C=C1)C(=C2C=CC(C=C2)=[N+](C)C)C3=C4C=CC(=CC4=CC(=C3O)S([O-])(=O)=O)S(O)(=O)=O

InChI

InChIKey=QEFJYMFUMVHTBR-UHFFFAOYSA-N

InChI=1S/C27H26N2O7S2/c1-28(2)20-9-5-17(6-10-20)25(18-7-11-21(12-8-18)29(3)4)26-23-14-13-22(37(31,32)33)15-19(23)16-24(27(26)30)38(34,35)36/h5-16H,1-4H3,(H2,31,32,33,34,35,36)

HIDE SMILES / InChI

Molecular Formula	C27H26N2O7S2
Molecular Weight	554.635
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21836630 | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16a8622b-b349-4b10-b45a-f1f1551b2b06

Acid green 50 (Lissamine Green B) is a synthetically produced organic acid dye with two aminophenyl groups. Acid green 50 is extensively used as a food dye and has a medical application as a staining agent. Due to its low toxicity and ability to stain dead and damaged cells the dye (in form of lissamine green strips) was approved as a tool for diagnosis of eye diseases associated with the damage of ocular surface epithelial cells.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Dead or degenerated cells 2 Target ID: Dead or degenerated cells Sources: https://www.ncbi.nlm.nih.gov/pubmed/7510270	Interacts 323

Conditions

Condition	Modality	Targets	Highest Phase	Product
Eye diseases 25 Sources: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16a8622b-b349-4b10-b45a-f1f1551b2b06	Diagnostic		Approved 8429	LISSAMINE GREEN Approved Use For use as a diagnostic agent when superficial corneal or conjunctival tissue change is suspected.

PubMed

Title	Date	PubMed
Factors affecting the uptake of lissamine green by serum proteins.	1960 Mar	13803681
Lissamine green--a supravital stain for determination of corneal endothelial viability.	1967 Oct	4168462
Micro-determination of inulin concentration in a solution containing lissamine green.	1970 Sep	5312657
Optimizing evaluation of Lissamine Green parameters for ocular surface staining.	2011 Nov	21836630
Symptoms of Dry Eye Disease and Personality Traits.	2016	27861642
Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up.	2016 Nov	26823393

Patents

Sample Use Guides

In Vivo Use Guide

For best viewing and patient comfort, acid green 50 (Lissamine Green) impregnated tip should be moistened with one or two drops of sterile irrigating or saline solution before application. Apply moistened tip to conjunctiva or fornix as required. It is recommended that the patient blink several times after application.

Route of Administration: Other

In Vitro Use Guide

Human corneal epithelial (HCE) cells were exposed to 1, 0.5, or 0.1% of acid green 50 (lissamine green) and the cells viability was studied. No observable staining of healthy HCE cells was noted with acid green 50.

Substance Class	Chemical Created by `admin` on `Sat Dec 16 08:39:38 GMT 2023` Edited by `admin` on `Sat Dec 16 08:39:38 GMT 2023`
Record UNII	BSU2XR3AKK
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Acid Green 50 parent

Common Name

English

Methanaminium, N-[4-[[4-(dimethylamino)phenyl](2-hydroxy-3,6-disulfo-1-naphthalenyl)methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, inner salt

Systematic Name

English

Code System Code Type Description

ECHA (EC/EINECS)

246-822-5